Trouble is brewing in the Ghana market for Bliss GVS Pharma, over an anti-malarial product sold by it in the African country.
Ghana’s Food and Drugs Authority has said that it black-listed Bliss from “manufacturing of medicines and other medicinal products for the Ghanaian market.”
The company had made a fake anti-malarial medicine (Gsunate plus suppositories), which was imported into the Ghana market. The efficacy and safety of the product had not been checked since there had not been a clinical trial study to justify the use of this product for malaria, the Ghana FDA said.
The regulator further mentions that a director with Bliss had “confessed to the FDA that this anti-malarial medicine is not used for treatment of malaria in children in India. The Director of Bliss GVS Pharma Ltd, India also admitted that the Gsunate Plus Suppository is a fake anti-malarial medicine,” the FDA note said.
A Bliss representative, speaking on conditions of anonymity and without getting into the details, denied any wrong-doing on its part.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.